Article
A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
Oncotarget - 7 Jun 2016
Wang Chengyuan, Sturgis Erich M, Chen Xingming, Wei Qingyi, Li Guojun
Abstract excerpt
IL-1a, an important regulator of immune and inflammation responses, has been implicated in cancer development and prognosis. An insertion (Ins)/deletion (Del) polymorphism (IL-1a rs3783553) in the 3' UTR of IL-1a may disrupt a binding site for miRNA-122 and may affect its transcription level. Thus, this polymorphism may cause interindividual variation in immune and inflammation responses and thus may lead to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
